Key facts
| Price (PPV) | 9,407 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | darbepoeitin alfa |
| Class | Antianemic preparations |
| ATC code | B03XA02 |
| Manufacturer | FRESENIUS MEDICAL CARE PHARMA AFRIQUE |
| Presentation | Boîte de 4 seringues |
| Hospital price | 9,230 MAD |
| Data collected on | 9/8/2026 |
Indications
Traitement de l’anémie symptomatique liée à l’insuffisance rénale chronique (IRC) chez l’adulte et l’enfant. Traitement de l’anémie symptomatique chez des patients adultes atteints de pathologies malignes non myéloïdes et recevant une chimiothérapie.
Find an open pharmacy
On-call pharmacies near you
About Aranesp 150 µg
Aranesp 150 µg belongs to the antianemic preparations therapeutic class. In Morocco, this drug is marketed by FRESENIUS MEDICAL CARE PHARMA AFRIQUE and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Aranesp 150 µg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Aranesp 150 µg
Answers to common questions from Moroccan patients about this drug.